- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Abby L. Parsons
News 7 results
Press Release
December 8, 2022
King & Spalding Promotes 24 New Partners and 17 Counsel Across 15 Cities
In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires
December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities
In the News · Source: Berkeley Center for Law and Technology's Expert Series Podcast
August 23, 2021
Abby Parsons and Jim Brogan appear on UC Berkeley Law’s Expert Series Podcast to discuss the DUSA Pharmaceuticals, Inc. v. Biofrontera Inc. case
In the News · Source: The Am Law Litigation Daily and St. Louis Post-Dispatch
Events 11 results
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Conference
November 1, 2022
Pharmaceutical University 2022
Speaking Engagement
June 2, 2022
Abby Parsons, Ellen Min to Speak at Rocky Mountain Intellectual Property & Technology Law Institute
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Insights 2 results
Client Alert
June 13, 2017
The Age of Competition
Newsletter
January 25, 2017
International Food Law Gazette - January 2017